Core Viewpoint - MEDIROM Healthcare Technologies Inc. has secured a new unsecured short-term bank loan of JPY350 million (approximately $2.4 million) to strengthen its financial position and support the development of its Mother Bracelet product [1][2] Financial Details - The loan amount is JPY350 million, with JPY200 million allocated for repaying debts of MEDIROM Mother Labs Inc., a subsidiary and guarantor of the loan [1] - The remaining funds will be used for general working capital, including the development of the Mother Bracelet [1] - The loan carries an interest rate of 1.875% per year [1] Company Overview - MEDIROM operates 308 relaxation salons across Japan, with its leading brand being Re.Ra.Ku® [6] - The company entered the health tech sector in 2015 and launched healthcare programs using an on-demand training app called "Lav®" [6] - In 2020, MEDIROM developed a smart tracker named "MOTHER Bracelet®" and launched a remote monitoring system called REMONY in 2023 [6] - The company aims to collect and manage healthcare data to become a leader in big data within the healthcare industry [6]

Core Insights - MEDIROM Healthcare Technologies Inc. announced a second investment by Yasuhiro Hayami, Chief Business Officer of MEDIROM Mother Labs Inc., in the Series A financing at a pre-money valuation of JPY9 billion (approximately US$60 million) [1] - This investment follows Mr. Hayami's initial investment in December 2024, indicating his commitment to the company's growth potential and alignment with MEDIROM's corporate philosophy [1] Company Overview - MEDIROM Mother Labs Inc. is a subsidiary of MEDIROM Healthcare Technologies Inc., focusing on the health-tech sector [6] - The company offers the "Specific Health Guidance Program" through the "Lav" health application and has developed the 24/7 recharge-free MOTHER Bracelet, which is a smart tracker [6][8] - The MOTHER Bracelet utilizes innovative technology to generate power based on temperature differences, allowing it to operate without recharging and recording key health metrics [8][9] Executive Background - Yasuhiro Hayami has a diverse career, including roles as Executive Officer at transcosmos inc. and founder of Wise, Inc., before becoming the Chief Business Officer of MEDIROM Mother Labs in 2024 [2][6]

Core Insights - MEDIROM Healthcare Technologies Inc. announced a second investment by Yasuhiro Hayami, Chief Business Officer of MEDIROM Mother Labs Inc., in the Series A financing at a pre-money valuation of JPY9 billion (approximately US$60 million) [1] - This investment follows Mr. Hayami's initial investment in December 2024, indicating his commitment to the company's growth potential and alignment with MEDIROM's corporate philosophy [1] Company Overview - MEDIROM Mother Labs Inc. is a subsidiary of MEDIROM Healthcare Technologies Inc., focusing on the health-tech sector [6] - The company offers the "Specific Health Guidance Program" through the "Lav" health application and has developed the MOTHER Bracelet, a 24/7 recharge-free smart tracker [6][8] - The MOTHER Bracelet utilizes innovative technology to generate power based on temperature differences, allowing it to record key health metrics without the need for recharging [8][9] Executive Background - Yasuhiro Hayami has a diverse career, including roles as Executive Officer at transcosmos inc. and founder of Wise, Inc., before becoming the Chief Business Officer of MEDIROM Mother Labs in 2024 [2][6]

Core Insights - MEDIROM Healthcare Technologies Inc. reported preliminary financial results for the year ended December 31, 2024, indicating sustained revenue growth and improved operating profitability [1][12] - The company expects total revenue of approximately JPY 8.2 billion ($52.6 million), a projected increase of JPY 1.4 billion ($9.2 million) from the previous year [5][8] - Adjusted operating income is anticipated to be around JPY 160 million ($1.0 million), marking a significant recovery from an operating loss in 2023 [5][12] Financial Performance - Total revenue for 2024 is projected at JPY 8.2 billion ($52.6 million), driven by increased sales of salons, store outsourcing revenue, and revenue from a newly acquired rehabilitation business [5][12] - Adjusted operating expenses are expected to be approximately JPY 8.12 billion ($51.6 million), reflecting an increase of JPY 0.9 billion ($5.7 million) due to higher costs associated with salon operations and professional fees [5][8] - The adjusted operating income of JPY 160 million ($1.0 million) represents a recovery of JPY 552 million ($3.5 million) from the previous year's operating loss [5][12] Key Performance Indicators - The total number of salons operated by the company was 308 as of December 2024, serving 945,395 customers throughout the year [10][20] - Average sales per customer were JPY 7,111 ($45.2), with a repeat customer ratio of 76.3% [10] - The average operation ratio stood at 45.7% for the year [10] Management Commentary - The CEO expressed satisfaction with the revenue growth and improved operating income, attributing success to the recovery from the COVID-19 pandemic and the growth in salon sales to investors [12] - The company aims to maintain its growth momentum into 2025 while completing the audit of its financial results under U.S. GAAP [12][16]

Core Insights - MEDIROM Healthcare Technologies Inc. reported updated Key Performance Indicators (KPIs) for December 2024, highlighting growth in sales per customer and overall salon performance [1][2]. Salon Operation Business - Sales per customer increased to JPY 7,384 in December 2024 from JPY 7,271 in December 2023, indicating a year-over-year growth [2]. - In December 2024, the company operated 308 salons, serving a total of 80,764 customers with a repeat customer ratio of 77.6% and an operation ratio of 45.9% [3][4]. Health Tech Business (Lav®) - The company offers a health guidance program using the Lav® app, which provides remote support to individuals at risk of lifestyle-related diseases [6][7]. - As of December 2024, MEDIROM has contracts with 97 corporate insurance associations, with a cumulative user base of 8,816 individuals utilizing the Lav® app [9][10]. Market Context - The Japanese government has set targets for specific medical checkup implementation rates at 70% and health guidance implementation rates at 45%, with current rates at 56.5% and 24.6% respectively, indicating potential market growth for health services [8].

Core Points - MEDIROM Healthcare Technologies Inc. completed its offering of 2,860,000 common shares, generating approximately $5 million in gross proceeds [1][2] - This offering is noted as the first follow-on registered underwritten public offering in the U.S. by a Japanese company listed solely on a U.S. stock exchange [2] - The proceeds from the offering will be used for working capital and general corporate purposes, including investments, acquisitions, and the development of new services [3] Company Overview - MEDIROM operates over 300 wellness salons in Japan, with its leading brand being Re.Ra.Ku®, and has expanded into health tech since 2015 [6] - The company has developed various healthcare programs and devices, including the "Lav®" training app and the "MOTHER Bracelet®" smart tracker [6] - In 2023, MEDIROM launched REMONY, a remote monitoring system for corporate clients, receiving orders from diverse industries such as nursing care and transportation [6] - The company aims to leverage its health-related products and services to collect and manage healthcare data, aspiring to become a leader in big data within the healthcare sector [6]

Company Overview - MEDIROM Healthcare Technologies Inc. is a health technology and holistic healthcare company based in Tokyo, Japan, led by CEO Kouji Eguchi [1] - The company operates over 300 wellness salons across Japan, with its leading brand being Re.Ra.Ku® [6] - MEDIROM entered the health tech business in 2015 and launched the MOTHER Bracelet® in 2020, followed by the REMONY remote monitoring system in 2023 [6] Product Offerings - The MOTHER Bracelet is the world's first 24/7 recharge-free smart tracker, utilizing temperature differences to generate electricity, thus preventing data loss during recharging [3][4] - REMONY is a remote health monitoring system that combines the MOTHER Bracelet with a dedicated gateway for real-time health data management [4] - The system is customizable for various industries, including elderly care and health monitoring for night shift workers [4] Partnership and Implementation - MEDIROM's subsidiary, MOTHER Labs, is providing the REMONY system and MOTHER Bracelet to the Electronics Division of TOPPAN Inc. as part of their employee health management initiatives [1][2] - TOPPAN aims to enhance employee health by creating a safe living environment and enabling early detection of health issues through the use of REMONY [2] Industry Context - Employee health management has evolved into a key priority for companies, shifting from individual responsibility to corporate responsibility [2] - The integration of health technology solutions like REMONY reflects a growing trend in corporate wellness programs [2]

Company Overview - MEDIROM Healthcare Technologies Inc. is a health technology and holistic healthcare company based in Tokyo, Japan, led by CEO Kouji Eguchi [1] - The company operates over 300 wellness salons across Japan, with its leading brand being Re.Ra.Ku® [6] - MEDIROM entered the health tech business in 2015 and launched the MOTHER Bracelet® in 2020, followed by the REMONY remote monitoring system in 2023 [6] Product Offerings - The MOTHER Bracelet is the world's first 24/7 recharge-free smart tracker, utilizing temperature differences to generate electricity, thus preventing data loss during recharging [3][4] - REMONY is a remote health monitoring system that combines the MOTHER Bracelet with a dedicated gateway for automatic data synchronization and real-time management [4] - The system is customizable for various industries, including elderly care and health monitoring for night shift workers, allowing for early detection of health emergencies [4] Partnership and Initiatives - MEDIROM's subsidiary, MOTHER Labs, is providing its health monitoring system and smart tracker to the Electronics Division of TOPPAN Inc. as part of TOPPAN's employee health management initiatives [1][2] - TOPPAN aims to create a safe living environment for employees, particularly those on solo assignments, by utilizing REMONY for early detection of health abnormalities [2]

Core Insights - MEDIROM Healthcare Technologies Inc. reported an increase in total customers served and sales per customer for November 2024, indicating positive business growth [2][3] - The company maintains a stable repeat customer ratio, reflecting customer loyalty [2][3] Salon Operation Business - Total customers served rose to 75,760 in November 2024 from 75,290 in November 2023, marking an increase of 0.62% [2][3] - Sales per customer increased to JPY 7,055 in November 2024 from JPY 7,045 in the same month last year, a slight increase of 0.14% [2][3] - The repeat customer ratio remained unchanged at 77.5% year-over-year [2][3] - The operation ratio improved to 44.6% in November 2024 from 43.9% in the previous year [2][3] Number of Salons - As of November 2024, the company operated 308 salons, a slight decrease from 311 in January 2024 [3][21] - The number of salons with available data was 283 in November 2024 [3] Health Tech Business (Lav®) - The company has entered into contracts with 95 corporate insurance associations, with a cumulative user base exceeding 8,515 individuals for its Lav® app as of November 2024 [16][21] - The health guidance program aims to assist individuals at risk of lifestyle-related diseases through remote support [8][15] Market Context - The Japanese government has set targets for specific medical checkup and health guidance implementation rates, which are currently below the desired levels, indicating potential market expansion opportunities for healthcare services [9]

Pre-Money Valuation of JPY9 Billion is Approximately Multiples of Current Parent Company Market Capitalization.Strategic Investors Further Validation of Technology and Growth Potential.Further Commercialization with Recent 25,000 Unit Order from B2B Sales Channel. TOKYO, Dec. 13, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) announces that its subsidiary MEDIROM MOTHER Labs Inc. raised to date an aggregate total of 260.3 million yen (approximtaely USD $ [1.7] million calculated ...